282 (Part 1): 305306
15 Potential Additional Benefits Several studies have investigated potential additional benefits of DPP-4 inhibitors, including microvascular and macrovascular effects, effects on blood pressure (BP) and weight, and risk of hypoglycemia
Additionally, results of the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results) trial have been announced, indicating a significant reduction in cardiovascular events (defined as cardiovascular death or nonfatal myocardial infarction or stroke) after up to 5 years of treatment with liraglutide versus placebo (13.0 vs
Gut 64 , 673683 (2015)
Daeshiho-tang attenuates inflammatory response and oxidative stress in LPS-stimulated macrophages by regulating TLR4/MyD88, NF-B, MAPK, and Nrf2/HO-1 pathways
Materials and methods Experimental chemicals and drugs Since doxorubicin, spirulina, and L-carnitine are commercially accessible, they were acquired at a nearby pharmacy in Egypt
